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Abstract
Efficient adaptive immune responses require the localization of T lymphocytes in secondary lymphoid organs and inflamed
tissues. To achieve correct localization of T lymphocytes, the migration of these cells is initiated and directed by adhesion
molecules and chemokines. It has recently been shown that the inhibitory surface molecule CD152 (CTLA-4) initiates Th cell
migration, but the molecular mechanism underlying this effect remains to be elucidated. Using CD4 T lymphocytes derived
from OVA-specific TCR transgenic CD152-deficient and CD152-competent mice, we demonstrate that chemokine-triggered
signal transduction is differentially regulated by CD152 via phosphoinositide 3-kinase (PI3K)-dependent activation of protein
kinase B (PKB/Akt). In the presence of CD152 signaling, the chemoattractant CCL4 selectively induces the full activation of
Akt via phosphorylation at threonine 308 and serine 473 in pro-inflammatory Th lymphocytes expressing the cognate
chemokine receptor CCR5. Akt signals lead to cytoskeleton rearrangements, which are indispensable for migration.
Therefore, this novel Akt-modulating function of CD152 signals affecting T cell migration demonstrates that boosting
CD152 or its down-stream signal transduction could aid therapies aimed at sensitizing T lymphocytes for optimal migration,
thus contributing to a precise and effective immune response.
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Introduction
Migration of immune cells, such as T lymphocytes, is a pre-
requisite for achieving adaptive immune responses. The recircu-
lation of T lymphocytes and their localization at sites of antigenic
challenge are regulated by the interaction of chemokines (CCL,
CXCL) with cognate chemokine receptors (CCR, CXCR) and
subsequently activated adhesion molecules. The expression of
diverse chemokine receptors characterizes different subsets of T
lymphocytes and drives their localization to specific tissues
(reviewed in [1]). For example, recirculating naı ¨ve T lymphocytes
are directed via the homeostatic CCR7 receptor to lymphoid
organs [2,3], whereas pro-inflammatory Th1 lymphocytes upre-
gulate the expression of CXCR3 and CCR5 [4] and are thereby
guided to inflamed tissues.
Chemokine receptors are G-protein-coupled receptors (GPCR),
which can be rapidly desensitized by G-protein-coupled kinases
(GRK) after agonist activation, resulting in limited migration
capacities [5,6]. Dissociating G-protein subunits can in turn
activate signaling cascades, including those involving protein
kinase C (PKC), mitogen-activated protein kinase (MAPK) and
PI3K. PI3K is known to regulate the migration of T lymphocytes
and ultimately leads to reorganization of the cytoskeleton, which is
necessary to achieve anterior-posterior orientation of immune cells
and for site-directed motility. Several target molecules of PI3K
have been shown to be involved in chemotactic processes, such as
Tec - Kinases, GTPases and Akt [7,8,9,10,11,12]. The small
GTPase Rac1 controls actin dynamics and membrane protrusions
[13]. Active Akt is recruited to the leading edge of cells and is
mainly involved in the development of cell orientation via the
reorganization of actin filaments.
Costimulation is required by T lymphocytes to achieve full
activation, which is associated with proliferation, differentiation,
survival and migration. The main positive costimulator of these
cells is the constitutively expressed Ig family member CD28,
whereas its homologue CD152 is often reported to act as a
negative regulator of T cell activation [14,15,16]. Both molecules
bind to the B7 family members CD80 and CD86, with CD152
displaying a higher affinity and being upregulated upon T cell
activation. CD152 signaling in activated T lymphocytes, where the
CD152 pathway exerts its main function, has been shown to
induce cell cycle arrest, reduced cytokine production, survival and
migration. Signal transduction by CD152 is not well understood; it
has been shown that this molecule binds PI3K, Src homology 2
(SH2) domain-containing protein tyrosine phosphatase 2 (SHP-2)
and serine/threonine phosphatase 2A (PP2A) and mediates the
inactivation of pro-apoptotic molecules, such as Bad (Bcl-2-
antagonist of cell death) [14,15,17]. With respect to the central
signaling kinase Akt, CD152 signaling mediates Akt activation on
Th1 and Th2 lymphocytes, which in turn inactivates the Fas
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lived CD28
null population has been shown to maintain resistance
to apoptosis via the activation of Akt [19]. However, survival only
requires a low level of Akt phosphorylation in T lymphocytes [20],
and it is not known whether CD152 induces strong Akt activation
in T lymphocytes, which is necessary for migration.
The costimulatory molecules CD28 and CD152 both increase
integrin-mediated adhesion processes via b1-integrin receptors
and LFA-1 integrin and enhance chemokine-driven direction of T
lymphocytes into and within secondary lymphoid organs and
inflamed tissues [21,22,23,24]. Although the increase of Th1 cell
migration in the presence of CD152 signals is based on increased
expression of the chemokine receptors CCR5 and CCR7 [24], it is
likely that this is not the only mechanism mediated by CD152 to
drive migration. In this study, we show that Th1 lymphocytes
presenting similar levels of CCR5 and CCR7 expression exhibit
considerably improved migration when they receive a CD152
signal. Therefore, we hypothesized that intracellular signal
transduction via CCR5 in Th1 lymphocytes is controlled by
CD152 interference with CCR5 signaling, such as through
desensitization of CCR5, CCR5-mediated adhesion, CCR5-
mediated reorganization of the cytoskeleton and/or CCR5-
mediated dissociation of G-protein subunits that activate signaling
cascades, such as the MAPK and protein kinase C (PKC)
pathways. To analyze the signaling axis responsible for this
improved migration, we assayed key signal transduction molecules
involved in different chemokine receptor axes, including GRK2,
Erk, Rac, PKCh, PI3K, and Akt, in the absence or presence of
CD152 signaling via biochemical analysis and subsequent
functional analysis.
Materials and Methods
Mice
CD152-competent (CD152
+/+) and CD152-deficient (CD152
2/2)
OTII mice transgenic (tg) for the OVA-specific TCR
tg/tg in a
C57BL/6 background and C57BL/6 mice were bred under specific
pathogen-free conditions in the animal facility at the Federal Institue
of Risk Assessment Bundesinstitut fu ¨r Risikobewertung (Berlin) and
the animal facility at the Otto-von-Guericke University Magdeburg
and were used at 5 to 10 weeks of age.
Antibodies, cytokines and reagents
The following antibodies against murine antigens were used in
PE- and APC-conjugated forms: anti-CCR5 (C34-3448), PE-
conjugated rat IgG2C (BD Biosciences, Franklin Lakes, USA),
anti-CCR7 (4B12) and PE- and APC-conjugated ratIgG2a
(eBioscience, San Diego, USA). Anti-IL-4 (11B11) and anti-CD4
(GK-1.5/4) were purified from hybridoma supernatants using
protein G and were controlled by HPLC and FACS analysis.
Recombinant chemokines and recombinant IL-12 were purchased
from R&D Systems (Minneapolis, USA). For isolation of lympho-
cytes, magnetic microbeads, anti-CD4, anti-CD62L, anti-CD90,
and anti-FITC multisort microbeads were purchased from Miltenyi
Biotech (Bergisch Gladbach, Germany). The PI3 kinase inhibitors
wortmannin and Ly294.002 were obtained from Sigma Aldrich (St.
Louis, USA). Akt inhibitor II (SH-5) and the PKCh inhibitor
Rottlerin were purchased from Calbiochem (Darmstadt, Germany).
Cell isolation and stimulation
Isolation of naı ¨ve CD62L
highCD4
+ T lymphocytes from
CD152-competent and CD152-deficient OTII mice was per-
formed using magnetic cell separation (MACS
TM, Miltenyi,
Bergisch Gladbach, Germany). Isolated TCR
tg CD152-deficient
CD4
+ T lymphocytes were controlled to prevent them from
undergoing spontaneous proliferation, as is observed in CD152
knockout CD4
+ T lymphocytes (data not shown, reviewed in [16]).
These cells were stimulated with 5 mg/ml OVA323–339 peptide
(provided by Schneider-Mergener, Charite ´, Berlin, Germany) and
using T cell-depleted splenocytes as APCs. On day 6 after the
onset of stimulation, the recall response was initiated by adding
freshly isolated APCs and OVA peptide to density gradient-
purified cells. For Th1 polarization, recombinant IL-12 (10 ng/
ml) and anti-IL-4 (6 mg/ml) were added to the cultures. The
differentiation of TCR
tg CD152-competent or CD152-deficient
Th1 lymphocytes was routinely controlled so that the cells showed
similar expression of activation-associated molecules (CD25,
CD44, CD62L
low, IFNc), as demonstrated previously (Fig. 7 in
[24]).
Chemotaxis assay
Th1 lymphocytes were collected on days 4–6 following the
initiation of the recall response. After density centrifugation using
Histopaque 1083 (Sigma Aldrich, St. Louis, USA), chemotaxis
assays were performed using 5 mm pore-size polycarbonate
Transwell filters (Corning Inc., Corning, USA). A total of 5610
5
cells in 100 ml of assay medium were added to fibronectin-coated
filters (10 mg/ml, Invitrogen, Darmstadt, Germany), and a
chemokine dilution (10 nM CCL4, 10 nM CCL19) or medium
was added to the lower chambers. Migrated lymphocytes were
recovered after 90 min of incubation at 37uC. The frequency of
migrated lymphocytes was determined by staining with anti-CD4
(L3T4, BD Biosciences, Franklin Lakes, USA) and comparing the
numbers to a fixed amount of fluorescent beads (Fluoresbrite
microparticles 20 mm, Polysciences Inc., Warrington, USA) by
flow cytometry. All determinations were performed in triplicate.
The chemotactic index indicates the ratio of Th lymphocytes that
migrated in response to chemokine versus medium treatment.
Phospho-protein staining
Phosphorylated isoforms of ERK and Akt were detected by flow
cytometry. T lymphocytes were starved in serum-free medium for
3 hours, and chemokine receptors were activated triggered by the
addition of 50 nM CCL4 for the indicated times. The cells were
immediately fixed in 2% paraformaldehyde and were permeabi-
lized with 90% methanol prior to staining with phospho-specific
Akt (pSerine 473 and pThreonine 308); pan-Akt antibodies (Cell
Signaling Technology, Danvers, USA); or PE-conjugated phos-
pho-specific Erk1/2 antibodies (BD Biosciences, Franklin Lakes,
USA) for 1 h at room temperature (RT). Akt antibodies were
detected using a goat anti-rabbit IgG-Alexa488-conjugated
secondary F(ab)2-antibody (Cell Signaling Technology, Danvers,
USA) following incubation for 30 min at RT.
G-LISA and western blot analyses
G-LISA was performed according to the manufacturers’
instructions (Cytoskeleton, Denver, USA). Briefly, on day 5
following initiation of the recall responses, T lymphocytes were
starved in serum-free medium for 3 hours. Rac activation was
induced in 2610
6 T lymphocytes by the application of 20 nM
CCL4 for the indicated times. The cells were then immediately
lysed and snap frozen. The protein concentrations of all samples
were equalized, and 15 mg of protein (in 50 ml) was applied to a
Rac-GTP-binding microplate in duplicate. Active Rac was
identified by incubation with an anti-Rac 1,2,3-recognizing
antibody followed by an HRP-coupled secondary antibody, and
detection was performed at 490 nm using a TECAN-infinite
M200-luminometer.
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follows: 5610
6 lymphocytes were starved in serum-free medium
for 3 hours prior to the addition of stimulating chemokines. The
cells were placed on ice, washed in ice-cold PBS and lysed. The
lysates were incubated with reducing Laemmli buffer for 5 min at
95uC, run on a 12.5% polyacrylamide gel, and transferred to a
nitrocellulose membrane. The membrane was than incubated with
anti-GRK2 (Y137, Abcam, Cambridge, UK), anti-phospho-
GRK2 (pSerine S670, Abcam), or anti-a-tubulin (DM1A,
Calbiochem, Darmstadt, Germany). HRP-coupled secondary
antibodies (Abcam) were used for detection with ECL reagents
(GE Healthcare, Buckinghamshire, UK). The band intensity of
pGRK2 relative to GRK2 was quantified using Image Gauge 4.0
software (Fuji Photo Film, Tokyo, Japan).
Statistical analysis
Statistical analysis was performed using a two-tailed unpaired
Student’s t-test (Figures 1, 2, 3), and p,0.05 (*), p,0.01 (**), and
p,0.001 (***) were considered to represent significant differences.
Results
Chemokine receptor expression provides limited
information regarding CD152-mediated chemotactic
capacity
The expression of chemokine receptors on the surface of
immune reactive cells has often been used to predict migratory
behavior. To investigate if this is also the case for CD152-mediated
migration [24], we stimulated CD4
+ T lymphocytes from
OTII
tgCD152-deficient and OTII
tgCD152-competent mice with
OVA peptide and used CD90-depleted splenocytes as APCs, with
some of these experiments being performed under Th1 conditions,
as indicated. The cells were used 3 days after the initiation of a
recall response for detection of chemokine receptors or for
functional migration assays in transwell systems. We determined
that CCR7 expression was correlated with the chemotactic
response to the corresponding chemokine, CCL19 (Fig. 1 A).
CD152-deficient T lymphocytes showed low/no CCR7 expres-
sion, and only a few CD4
+ T lymphocytes migrated to CCL19.
Because the detection limit of the molecules commonly used in the
procedures for performing cytometric measurements is approxi-
mately 2,000 molecules per cell [25], these lymphocytes might still
express CCR7 at low levels that are sufficient to stimulate them to
migrate to CCL19. Accordingly, the elevated CCR7 expression in
CD152-competent Th lymphocytes resulted in 12-fold greater
attraction of Th lymphocytes to CCL19 than to the medium.
Following generation of Th1 lymphocytes by the addition of
recombinant IL-12 and blocking IL-4, almost no CCR7
expression was detected in CD152-deficient and CD152-compe-
tent T lymphocytes (Fig. 1 B, top panel). Nevertheless, an
improved chemotactic capacity was demonstrated in CD152-
competent CD4
+ T lymphocytes. The chemotactic index of
CD152-deficient lymphocytes in response to CCL19 remained by
1.2 whereas 4 times more CD152-competent T lymphocytes
migrated to CCL19 than to the medium control (Fig. 1 B, lower
panel). We have recently shown that the higher expression of the
pro-inflammatory chemokine receptor CCR5 on CD152-compe-
tent Th1 lymphocytes compared to CD152-deficient Th1
lymphocytes is correlated with an improved chemotactic response
to the binding of chemokine CCL4 on day 5 of a recall response
Figure 1. Chemokine receptor expression in activated T lymphocytes does not reflect the chemotactic capacities of corresponding
chemokines. CD4
+ T lymphocytes from TCR
tgCD152-deficient (CD152
2/2) and TCR
tgCD152-competent (CD152
+/+) mice were analyzed to detect
chemokine receptor expression by flow cytometry (upper panels) and in chemotaxis assays (lower panels) on day 3 after the initiation of recall
responses. A CCR7 expression and migration toward medium or CCL19 were detected in T lymphocytes. B Th1-differentiated CD4
+ T lymphocytes
were analyzed for CCR7 expression and migration behavior toward medium or CCL19. C Th1 lymphocytes exhibited similar CCR5 expression levels
(M1: TCR
tgCD152-deficient, 60%; TCR
tgCD152-competent, 60%) but different migration rates in transwell systems. Representative data from two
experiments are shown.
doi:10.1371/journal.pone.0031391.g001
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a recall response, when Th lymphocytes are still in an activated
state, revealed similar expression of CCR5 on 60% of both
TCR
tgCD152-deficient and TCR
tgCD152-competent Th1 lym-
phocytes (Fig. 1 C, top panel). However, CD152-deficient Th1
lymphocytes exhibited 2.8 times more migration to the chemoat-
tractant CCL4 than to the medium at this time point (Fig. 1 C,
lower panel), whereas CD152-competent Th1 lymphocytes
presented a chemotactic index close to 10, representing a 3-fold
higher migration rate than CD152-deficient Th1 lymphocytes
(Fig. 1 C, lower panel). Thus, expression of the chemokine
receptor CCR5 on TCR
tgCD152-deficient and TCR
tgCD152-
competent Th1 lymphocytes does not explain the migration
capacities of T lymphocytes, and CD152 signals likely affect
chemokine receptor functionality.
CD152 controls the specific migration of T lymphocytes
by affecting signal transduction via CCR5
Despite similar expression of chemokine receptors, the en-
hanced specific migration of CD152-competent lymphocytes
points toward a CD152-mediated mechanism altering intracellular
signal transduction via CCR5. To monitor the CD152-controlled
signal transduction pathways associated with CCR5, we now have
an available system involving activated T-cells (+/2 CD152
engagement) showing equal expression of chemokine receptors
(Fig. 1). Using this system, we examined several typical signal
transduction molecules induced by chemokine binding to CCR5,
which is responsible for mediating the desensitization of CCR5
and reorganization of the cytoskeleton and may indicate dissocia-
tion of the G-protein subunits of CCR5, to identify the molecules
responsible for the CD152-mediated increase in the directed
migration of Th1 lymphocytes (Fig. 2, 3). We generated Th1
lymphocytes from TCR
tgCD152-deficient and TCR
tgCD152-
competent mice. On day 2 and day 5 after the initiation of the
recallresponse,thelymphocyteswerestarvedinserum-freemedium
for 3 hours prior to the induction of chemokine receptor signaling
via the addition of the chemokine CCL4 for the indicated times.
Activation of the MAPK pathway was assessed by analyzing the
phosphorylated, active isoform of ERK byflowcytometry(Fig.2 A).
No effect was detected following triggering with CCL4 for 5 min or
20 min compared to the ERK phosphorylation of Th1 lymphocytes
during a recall response without the addition of a chemokine,
independent ofthe presenceofCD152signals.Instead,thesignaling
molecule PKCh, which has been shown to control chemokine
Figure 2. Effect of induction with the chemokine CCL4 on signaling molecules. A Th1 lymphocytes from TCR
tgCD152-deficient and
TCR
tgCD152-competent mice were analyzed for ERK phosphorylation on day 2 and day 5 of a recall response. Signaling via CCR5 was induced in
serum-starved lymphocytes by treatment with 20 nM CCL4 for 5 (heavy black line) or 20 min (heavy grey line). Filled histograms indicate ERK
phosphorylation before CCL4 application. B Migration assay in Th1 lymphocytes from TCR
tgCD152-deficient and TCR
tgCD152-competent mice on day
5 of a recall response. A portion of the lymphocytes was incubated with the PKCh-specific inhibitor Rottlerin for 20 h. C Western blot detection of
signaling proteins in lysates of TCR
tgCD152-deficient and TCR
tgCD152-competent Th1 lymphocytes on day 5 of a recall response. The cells were
treated as described in Fig. 2 A. D The band intensity of pGRK2 relative to GRK2 was quantified using Image Gauge 4.0. Representative data from at
least two experiments are shown.
doi:10.1371/journal.pone.0031391.g002
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the CD152-mediated migration of Th1 lymphocytes (Fig. 2 B).
Lysates of TCR
tgCD152-deficient and TCR
tgCD152-competent
Th1 lymphocytes were tested to detect the phosphorylated isoform
of PKCh after chemokine receptor triggering via the addition of
CCL4. Treatment with CCL4 for 5 min led to a 20% increase in
the level of active PKCh in CD152-deficient CD4 T lymphocytes,
compared with a 40% enhancement of PKCh activation in the
presence of CD152 signals (data not shown). PKCh-dependent
migration following CD152 signaling was tested functionally using
the PKCinhibitorRottlerin, whichis specificforthe PKCh isoform.
The specific migration of CD152-deficient Th1 lymphocytes,
measured based on the chemotactic index, was inhibited by
approximately 30% in the presence of Rottlerin, whereas the
chemotactic index of CD152-competent Th1 lymphocytes was
reduced twofold (63%) (Fig. 2 B).
Next, we analyzed the role of CD152 signaling during the
desensitization of CCR5, which mediates the rapid modulation of
migration capacities [27]. To determine the axis responsible for
signaling via G-protein-coupled kinases (GRKs), we analyzed the
typical signal transduction molecule GRK2. GRK2 is a suitable
candidate for investigating the differential migration of T
lymphocytes because ligand-bound receptors may vary in their
functionality due to binding antagonistic chemokines or via
phosphorylation through GRKs, especially GRK2, and the
sequential binding of b-arrestins [27]. We analyzed TCR
tg Th1
lymphocytes in the absence or presence of CD152 signals to detect
GRK2 and its phosphorylated, catalytically inactive isoform on day
5 following the initiation of a recall response (Fig. 2 C). Chemokine
receptor signals were induced by CCL4 treatment for the indicated
times, and protein lysates were tested to detect GRK2 isoforms
using western blotting. GRK2 remained unchanged following
CCL4 induction in TCR
tgCD152-deficient and TCR
tgCD152-
competent Th1 lymphocytes when compared with the a-tubulin
control. However, inactive GRK2 (pGRK2) was found to be
selectively increased in TCR
tgCD152-competent Th1 lymphocytes
after chemokine induction for 5 min, and a 35-fold increase in the
pGRK2/GRK2 ratio was observed, which permits prolonged
signal transduction via the chemokine receptor (Fig. 2 C, D).
CD152 signal transduction activates Akt
Next, we analyzed whether CD152 signaling interferes with the
signaling axis involved in the chemokine-dependent trafficking of
T lymphocytes from peripheral blood vessels to tissues [28]. For
Figure 3. Chemokine receptor signaling affects signaling molecules involved in cytoskeleton rearrangements. A Activated Rac was
detected by G-LISA in Th1 lymphocytes from TCR
tgCD152-deficient and TCR
tgCD152-competent mice on day 5 of a recall response. Rac activation was
induced in serum-starved lymphocytes by treatment with 20 nM CCL4 for 5 or 20 min. B Th1 lymphocytes from TCR
tgCD152-deficient and
TCR
tgCD152-competent mice on day 5 of a recall response were incubated with or without 20 nM CCL4 for 5 or 20 min. Fixed and permeabilized
lymphocytes were analyzed by flow cytometry for Akt activation using antibodies specific for phosphorylated Akt or total Akt. A protion of the
lymphocyteswere incubated for 20 h with the PI3K inhibitor Ly294.002 (filled histograms). Histograms show the expression of Akt on T lymphocytes.
C Th1 lymphocytes from TCR
tgCD152-deficient and TCR
tgCD152-competent mice were analyzed to determine their migration affinities for the
inflammatory chemokine CCL4 in a transwell system on day 5 of a recall response. A portion of the Th1 lymphocytes were incubated for 20 h with a
PI3K inhibitor or Akt inhibitor II, as indicated. The dotted line indicates basal migration toward medium (ns, not significant). Representative data from
at least two experiments are shown.
doi:10.1371/journal.pone.0031391.g003
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PI3K and its downstream target Rac. Rac is a small GTPase that
is a key player in cell spreading, polarization and leading edge
formation [15,29]. We detected the activity of Rac using G-LISA
assays in lysates of TCR
tgCD152-deficient and TCR
tgCD152-
competent Th1 lymphocytes on day 5 following the initiation of a
recall response. We induced CCR5 chemokine receptor signaling
in Th1 lymphocytes of TCR
tgCD152-deficient and TCR
tgCD152-
competent mice via the application of CCL4 for 5 or 20 min (Fig. 3
A). The increase in Rac activation was similar over the examined
time periods and did not depend on CD152 signaling (Fig. 3 A).
The activation of another main target of PI3K, Akt, was also
analyzed in Th1 lymphocytes via flow cytometry on day 3 (data
not shown) and day 5 after the initiation of a recall response (Fig. 3
B). The total amount of Akt was comparable in CD152-deficient
and CD152-competent Th1 lymphocytes and was unchanged in
the presence of a PI3K inhibitor (Fig. 3 B, upper panel). In
contrast, using phospho-specific antibodies for cytometric analyses,
we determined that Akt activation was induced only in the
presence of CD152 signals. Thr308 is the first site to be
phosphorylated during the activation of Akt [30]. PI3K-dependent
Thr308 phosphorylation occurred within 5 min after the induc-
tion of chemokine receptor signaling via the addition of CCL4
(Fig. 3 B, middle panels). The phosphorylation of Thr308 in Th1
lymphocytes from TCR
tgCD152-competent mice remained stable
for at least 20 min. In addition, the sequential phosphorylation of
Akt at Ser670 was not detectable in Th1 lymphocytes from
TCR
tgCD152-deficient mice, although it was transiently up-
regulated 5 min after the addition of CCL4 in CD152-competent
CD4
+ Th1 lymphocytes (Fig. 3 B, lower panels).
Moreover, functional chemotaxis assays supported the relevance
of Akt activation with respect to the chemokine-induced migration
of TCR
tgCD152-competent Th1 lymphocytes (Fig. 3 C). Chemo-
taxis assays revealed that the chemotactic indices of CD152-
deficient Th1 lymphocytes were not reduced significantly in the
presence of the Akt inhibitor SH-5 or a PI3K inhibitor, whereas
treatment with either the PI3K inhibitor or the Akt inhibitor
decreased the migratory capacity of CD152-competent Th1
lymphocytes in a dose-dependent manner by up to 50% compared
to Th1 lymphocytes not treated with inhibitors. Thus, our data
unambiguously show that the central mechanism underlying
CD152-induced migration is activation of the PI3K-Akt pathway.
This study shows that Th1 lymphocytes presenting similar levels
of CCR5 and CCR7 expression exhibit improved migration
following receiving a CD152 signal. Using biochemical and
functional assays, we show that CD152-mediated control of
specific migration is at least partially mediated by CD152
inhibition of GRK2, although this process is mainly regulated by
the full activation of Akt, and both mechanisms together enhance
the capacity of Th1 lymphocytes to direct migration toward
inflammatory CCL4. Thus, our data show that CD152 controls at
least two signaling axes associated with CCR5 (Fig. 4).
Discussion
CD152 signals enhance the motility [23] and the chemotaxis of
Th1 lymphocytes [24]. The results of this study point to a
mechanism underlying the increased directed migration of Th1
lymphocytes mediated by CD152 signals based on prolonged
chemokine receptor signaling and PI3K-dependent Akt activation.
Our results clearly demonstrate that the expression of
chemokine receptors reveals only limited information regarding
the migratory capacities of T lymphocytes and indicate the
usefulness of monitoring via functional migratory assays (Fig. 1).
Differential migratory affinities toward CXCL12 have been
described in B lymphocytes. However, the single chemokine
receptor CXCR4 is present at all stages of B cell development
[31]. Furthermore, it has been shown that the chemokine receptor
CCR7, which is assumed to be down-regulated due to differen-
tiation of Th1 or Th2 lymphocytes [32], directs Th1 lymphocytes
toward its ligands CCL19 and CCL21 in functional assays [33]. In
our system and others, the low levels of expression and rapid
recycling of chemokine receptors may explain the restricted
detection of their surface expression.
A characteristic molecule that induces cytoskeleton rearrange-
ments is the small GTPase Rac. Rac, together with the GTPase
Cdc42, organizes actin polymerization at the leading edge of cells,
which is necessary for motility (reviewed in [34]). However, using
G-LISA assays, we did not detect significant differences in Rac
activation in CD152-deficient or CD152-competent Th1 lympho-
cytes following triggering with the CCR5 ligand CCL4 (Fig. 3 A).
Moreover, recent studies have shown that T cell motility can be
maintained, independent of Rac activation and F-actin polymer-
ization by L-plastin, via regulation of the stability and the
polarization of F-actin and CCR7 [35]. Whether Rac activation
is initiated in CD152-competent and CD152-deficient Th1
lymphocytes by the same signaling pathways involved in the
activation of chemokine receptors, such as PI3K and Akt, remains
to be determined. CD152-deficient lymphocytes may differentially
activate Rac via integrin adhesion signals, whereas CD152-
competent lymphocyte chemotactic signals likely involve Akt and
Rac activation [34].
Although we could not detect a reduction in the total amount of
GRK2 in TCR
tgCD152-competent Th1 lymphocytes compared
to TCR
tgCD152-deficient Th1 lymphocytes (Fig. 2 C), chemokine
receptor signaling is likely dependent on GRK2 [27]. Because
GRK2 is a ubiquitous molecule, the generally high levels of GRK2
in T lymphocytes [36] may obscure any chemokine-induced
changes in total GRK2 in our system. Indeed, chemokine-induced
migration of T lymphocytes has been shown to be attenuated by
GRK2 (reviewed in [27,37]). In accordance with our findings,
decreased levels of GRK2 expression in GRK2
+/2 mice were
previously proposed to enhance migration toward the CCR5
ligand CCL4 [38]. However, the catalytically inactive isoform of
GRK2, which is phosphorylated at serine 670 [6], was found to be
present in increased levels in TCR
tgCD152-competent Th1
lymphocytes, leading to decreased desensitization of the chemo-
kine receptor by b-arrestins, which bind to phosphorylated
receptors. The reassociated G-proteins recouple with the chemo-
kine receptor, allowing prolonged signal transduction via CCR5
expressed on the cell surface (Fig. 2 C, D). Additionally, other
desensitization mechanisms not examined in the present study
may be involved, as it has been reported for CCR5 that ligand-
bound receptors can pass through endosomal recycling pathways
without the dissociation of chemokines, following which function-
ally desensitized CCR5 is re-expressed at the cell surface [39].
It is unlikely that the differences in migration and chemokine-
induced signal transduction in the presence and absence of CD152
are due to enhanced CD28 engagement, as this would be reflected
in altered expression of activation-associated molecules, such as
CD69, CD44, and CD25, which is not the case under the
conditions employed in the present study [24]. Moreover, no
differences were detected between CD152-deficient and CD152-
competent Th1 lymphocytes concerning the activation of the
signaling molecules ERK, GRK2, Akt or PKCh prior to
chemokine addition (Fig. 2 A, C and data not shown). The
ERK pathway does not appear to be involved in CD152-mediated
migration, as stimulation with CCL4 did not increase its activation
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homeostatic CXCL12 in B lymphocytes [40] and CXCL8 in T
cell lines [41], this may differ in the case of primary Th1
lymphocytes because signaling pathways vary in terms of the cell
type, ligands, receptors and kinetics involved. Additionally, the
diverse chemokine receptor profiles expressed by different T cell
subpopulations, such as antigen-experienced resting T lympho-
cytes and naı ¨ve or recently activated T lymphocytes [32], most
likely influence signaling pathways differently.
Akt was selectively activated by chemokine induction in CD152-
competent Th1 lymphocytes (Fig. 3 B), and chemotaxis induced
via CCR5 was markedly reduced in the presence of Akt or PI3K
inhibitors (Fig. 3 C). These data correspond to the described roles
of PI3K in lymphocyte migration of mediating gradient sensing
and cytoskeleton rearrangements [28,34,42]. Recently, differences
in the dependency of PI3K signals have been demonstrated
showing that the migration of human Th2 lymphocytes in vitro is
PI3K independent [43,44]. In contrast, the migration of isolated
human T lymphocytes toward CXCL4 ex vivo has been found to
be PI3K dependent, although after two days of TCR stimulation,
PI3K became irrelevant [45], and migration was regulated via
PKCh [26]. Our results reveal that the directed migration of
resting Th1 lymphocytes toward CCL4 remains dependent on
PI3K-mediated Akt signals (Fig. 3 B) and is influenced by PKCh
signals (Fig. 2 B). These inconsistent findings may be a result of the
different natures of the analyzed chemokine receptors and the
corresponding differences in their expression and, ultimately,
signaling properties. It is likely that inflammatory chemokine
receptors, such as CCR5, are superior to homeostatic chemokine
receptors because an inflammatory milieu creates an abundance of
chemokines and adhesion ligands, and inducible chemokine
receptors are expressed at higher levels than homeostatic ones.
Based on data for the CD28 and CD152 receptors for CD80/
CD86 ligands, we propose the following model for the regulation
of CCR5-directed migration (Fig. 4). Upon binding of its ligand,
CCL4, the CCR5 receptor is phosphorylated by CD28-induced
GRK2. b-arrestins can now bind to CCR5 and initiate the
desensitization process, which contributes to the degradation or
recycling of CCR5. Our data show that CD152 engagement leads
to the inactivation of GRK2, while the likely phosphorylation of
CCR5 is delayed or prevented. CD28 and CD152 signal-induced
activation of integrins via the Gbc-subunit and the GTPases Rac1
and Cdc42 or Rap1 ultimately leads to adhesion of lymphocytes
[23]. Chemokine-induced activation of PI3K and the subsequent
phosphorylation and activation of Akt are only initiated in the
presence of CD152 signaling, and it is only under these conditions
that specific migration along chemokine occurs. These data
together with the observations that (i) CD152 induces resistance
against activation-induced cell death [18,23]; (ii) CD152 mediates
the differentiation of high-quality memory T cells [46]; and (iii)
CD152 signals in activated T cells lead to reduced adhesion and
increased motility, which result in truncated T cell-APC
Figure 4. Role of CD28 and CD152 signals in signal transduction via the chemokine receptor CCR5 in Th1 lymphocytes. Upon binding
of its ligand, CCL4, the CCR5 receptor is phosphorylated by CD28-induced GRK2. b-arrestins can now bind to CCR5 and initiate desensitization, which
contributes to the degradation or recycling of CCR5. CD152 engagement leads to the inactivation of GRK2, and the phosphorylation of CCR5 is
prevented. CD28 and CD152 signal-induced activation of integrins by the Gbc subunit and via the GTPases Rac1 and Cdc42 or Rap1 ultimately leads
to lymphocyte adhesion. Chemokine-induced activation of PI3K and the subsequent phosphorylation and activation of Akt are only initiated in the
presence of CD152 signaling, and it is only under these conditions that specific migration occurs along chemokine gradients (orange arrows indicate
signal transduction under CD28 signaling, and blue arrows indicate signal transduction under CD152 signaling). The figure shows only those
signaling pathways controlled by CD152.
doi:10.1371/journal.pone.0031391.g004
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CD152 expression and signaling select high quality T cells out of a
heterogeneous population of stimulated T cells to become
chemotactic. An appropriately selected population with the ability
to migrate is important for the development of an effective and
appropriate adaptive immune response in the periphery. Thus,
CD152 might represent a master switch that determines the fate of
an effector T cell and, ultimately, the quality of the immune
response.
Our data suggest that full activation of Akt, which is necessary
for chemotactic processes [14] including the polarization of cells to
form an anterior-posterior axis [48,49] and the activation of actin
[50] to occur, is induced by CD152 signaling. In the absence of
CD152, the localization of Th1 lymphocytes would be dominated
by integrin-mediated, non-directed adhesion. Within the complex
chemokine receptor signaling pathways, CD152 signals could
enhance the Akt-mediated polarization of T lymphocytes and
allow directed migration to occur. Therefore, CD152 may
represent a promising target molecule for manipulating the
localization of T lymphocytes to lymph nodes or to inflamed
tissues, thereby, modulating immune responses.
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